Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Medtronic
Merck
McKesson
US Department of Justice

Generated: August 18, 2019

DrugPatentWatch Database Preview

Patent: 9,457,019

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,457,019
Title:Methods for inhibiting tie-2 kinase useful in the treatment of cancer
Abstract: The present invention relates to methods of inhibiting TIE2 kinase useful in the treatment of tumor growth, invasiveness, intravazation, dissemination, metastasis, and immunosuppression. Specifically, the invention relates to methods of using 1-(3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)-3-(2-fluoro-4-(2-(meth- ylcarbamoyl)pyridin-4-yloxy)phenyl)urea and salts thereof of Formula I.
Inventor(s): Flynn; Daniel L. (Lawrence, KS), Kaufman; Michael D. (Lawrence, KS), Smith; Bryan D. (Lawrence, KS), Rudoltz; Marc (West Orange, NJ)
Assignee: Deciphera Pharmaceuticals, LLC (Lawrence, KS)
Application Number:14/535,900
Patent Claims:see list of patent claims

Details for Patent 9,457,019

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125554 001 2015-11-23 ➤ Sign Up Deciphera Pharmaceuticals, LLC (Lawrence, KS) 2033-11-07 RX Orphan search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 002 2015-03-04 ➤ Sign Up Deciphera Pharmaceuticals, LLC (Lawrence, KS) 2033-11-07 RX search
Bristol Myers Squibb OPDIVO nivolumab INJECTABLE;INJECTION 125527 001 2015-03-04 ➤ Sign Up Deciphera Pharmaceuticals, LLC (Lawrence, KS) 2033-11-07 RX search
Genentech KADCYLA ado-trastuzumab emtansine VIAL; SINGLE-USE 125427 002 2013-02-22 ➤ Sign Up Deciphera Pharmaceuticals, LLC (Lawrence, KS) 2033-11-07 RX search
Genentech KADCYLA ado-trastuzumab emtansine VIAL; SINGLE-USE 125427 001 2013-02-22 ➤ Sign Up Deciphera Pharmaceuticals, LLC (Lawrence, KS) 2033-11-07 RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
McKesson
US Army
UBS
QuintilesIMS
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.